High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre

Australian and New Zealand Journal of Public Health

Volumn 33, Issue 3, 2009, Pages 280-283

  Salmon, Allison M ^a   Van Beek, Ingrid ^b   Amin, Janaki ^a   Grulich, Andrew ^a   Maher, Lisa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Sydney Medically Supervised Injecting Centre   (Australia)

Author keywords

Epidemiology; HIV prevalence; Injecting drug use; Psychostimulants; Supervised injecting facilities

Indexed keywords

PSYCHOSTIMULANT AGENT;

ARTICLE; BISEXUALITY; DRUG USE; HEALTH SERVICE; HEALTH SURVEY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; PREVALENCE; RISK FACTOR; SELF REPORT;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 67650463105     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2009.00389.x     Document Type: Article

References (13)

1. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2003-2007. Sydney (AUST): University of New South Wales; 2008.
2. Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295-303. (Pubitemid 39620222)
3. Law MG, Batey RG. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase. Med J Aust. 2003;178(5):197-198 (Pubitemid 36329208)
4. Department of Health and Ageing. Return on Investment in Needle and Syringe Programs in Australia. Canberra (AUST): Commonwealth of Australia; 2002.
5. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41(6):777-813. (Pubitemid 43995128)
6. NSW Government. NSW Drug Summit 1999: Government Plan of Action. Sydney (AUST): New South Wales Health; 1999.
7. van Beek I. The Sydney medically supervised injecting centre: a clinical model. Journal of Drug Issues. 2003;33(3):625-638 (Pubitemid 37205842)
8. National Centre in HIV Epidemiology and Clinical Research: Sydney Medically Supervised Injecting Centre Evaluation Report 4: Evaluation of Service Operation and Overdose-related Events. Sydney (AUST): University of New South Wales; 2007.
9. HIV testing among populations at risk for HIV infection - nine states, November 1995-December 1996: MMWR Morb Mortal Wkly Rep. 1998;47:1086-1091
10. UK Collaborative Group for HIV and STI Surveillance. Testing Times - HIV and Other Sexually Transmitted Injections in the United Kingdom. London (UK): Health Protection Agency, Centre for Infection; 2007.
11. Centres for Disease Control and Prevention. HIV/AIDS Surveillance Report 2001. HIV/AIDS Surveill Rep. 2001;13(1).
12. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia - Annual Surveillance Report 2007. Canberra (AUST): Australian Institute of Health and Welfare: 2007.
13. De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviours in a residential drug treatment population. Am J Epidemiol. 1996;143(7):725-732 (Pubitemid 26108239)